A Novel Prognostic Model for Risk Stratification in Younger Patients with Intermediate Risk Acute Myeloid Leukemia (AML)

Autor:	Matt Kalaycio, Hetty E. Carraway, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Bartlomiej P Przychodzen, Mikkael A. Sekeres, Brittney Dienes, David J. Seastone, Tom Radivoyevitch, Anjali S. Advani, Aziz Nazha, Jennifer S. Carew, Aaron T. Gerds
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Myeloid leukemia Hematology Secondary AML Molecular biomarkers Internal medicine Risk stratification medicine Prognostic model business Intermediate risk
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 15:S195-S196
ISSN:	2152-2650
DOI:	10.1016/j.clml.2015.04.048
Popis:	230 ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML? Jingmei Hsu, MD/PhD, Anita Kumar, MD/MS, Martin Carroll, MD, Noelle Frey, MD, Nirav Shah, MD, Jianhua Zhao, PhD, Elizabeth Hexner, MD, Alison Loren, MD/PhD, Alexander Perl, MD, David Porter, MD, Jennifer Morrissette, PhD, Selina Luger, MD Hematology/Oncology, Abramson Cancer Center of the University of Pennsylvania; Department of Pathology and Laboratory Medicine, Abramson Cancer Center of the University of Pennsylvania
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ddbe7961ab87f2242c9e68251b40bee5 https://doi.org/10.1016/j.clml.2015.04.048 Zobrazit plný text záznamu Full Text from ScienceDirect